Marta Maia Bosca-Watts

13PUBLICATIONS
97CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)AllergyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 29, 2026
Long-term use of subcutaneous infliximab biosimilar CT-P13 in patients with inflammatory bowel disease in clinical practice.

José María Huguet, Lidia Martí Romero, Marta Maia Boscá-Watts

|Jan 31, 2025
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.

Margalida Calafat, Carles Suria, Francisco Mesonero

|Jan 09, 2025
Inflammatory bowel disease vs strongyloidiasis.

Teresa García Ballester, Sheila González Padilla, Marta Maia Boscá-Watts

|Sep 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

María Chaparro, Sandra Hermida, Diana Acosta

Pageof 3